메뉴 건너뛰기




Volumn 27, Issue 7, 2016, Pages 1352-1353

Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATINE KINASE; PEMBROLIZUMAB; IMMUNOLOGICAL ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

EID: 84977090451     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdw126     Document Type: Letter
Times cited : (62)

References (5)
  • 1
    • 84929481481 scopus 로고    scopus 로고
    • Pembrolizumab versus ipilimumab in advanced melanoma
    • Robert C, Schachter J, Long GV et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015; 372: 2521-2532.
    • (2015) N Engl J Med , vol.372 , pp. 2521-2532
    • Robert, C.1    Schachter, J.2    Long, G.V.3
  • 2
    • 84964573640 scopus 로고    scopus 로고
    • Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
    • Champiat S, Lambotte O, Barreau E et al. Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper. Ann Oncol 2016; 27: 559-574.
    • (2016) Ann Oncol , vol.27 , pp. 559-574
    • Champiat, S.1    Lambotte, O.2    Barreau, E.3
  • 3
    • 84949988089 scopus 로고    scopus 로고
    • Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
    • Naidoo J, Page D, Li B et al. Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 2015; 26: 2375-2391.
    • (2015) Ann Oncol , vol.26 , pp. 2375-2391
    • Naidoo, J.1    Page, D.2    Li, B.3
  • 4
    • 84907996539 scopus 로고    scopus 로고
    • Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis
    • Min L, Hodi FS. Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis. Cancer Immunol Res 2014; 2: 15-18.
    • (2014) Cancer Immunol Res , vol.2 , pp. 15-18
    • Min, L.1    Hodi, F.S.2
  • 5
    • 68349092608 scopus 로고    scopus 로고
    • Autoimmune inflammatory myopathy after treatment with ipilimumab
    • Hunter G, Voll C, Robinson CA. Autoimmune inflammatory myopathy after treatment with ipilimumab. Can J Neurol Sci 2009; 36: 518-520.
    • (2009) Can J Neurol Sci , vol.36 , pp. 518-520
    • Hunter, G.1    Voll, C.2    Robinson, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.